Use Cases
Litigation Research Litigation Strategy Risk Analysis Business Development Active Matter Management Monitoring
Contact Us

Please enter minimum 2 characters

All
Litigation
Parties
Patents
News
Judges
Law Firms
Attorneys
Venues

Use Cases
Contact Us
Login

×

View as Organization

Injectable nanoparticulate olanzapine formulations

Injectable nanoparticulate olanzapine formulations

CN 101,106,972 A
Filed: 11/16/2005
Published: 01/16/2008
Est. Priority Date: 11/16/2004
Status: Active Application

EN CH
- Pin

Subscription Required

This content requires a subscription to view

Contact UsorLogin

Copyright © 2008-2024 RPX Corporation. All Rights Reserved.

Use Cases

Litigation Research
Litigation Strategy
Risk Analysis
Business Development
Active Matter Management
Monitoring

Quick Links

Contact Us
RPX Empower
RPX Analyst
RPX Corporation

Others

Privacy Policy
Terms of Use

×

×